The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines-Reference-Cited by-同舟云学术

The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines

Published:2019-10 Issue:4 Volume:54 Page:1901272
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Caminero José A.,García-Basteiro Alberto L.,Rendon Adrián,Piubello Alberto,Pontali Emanuele,Migliori Giovanni Battista^ORCID

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference33 articles.

1. World Health Organization. WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment. Geneva, World Health Organization, 2019.

2. World Health Organization. The Use of Molecular Line Probe Assays for the Detection of Resistance to Second-line Anti-tuberculosis Drugs. Policy Guidance. Geneva, World Health Organization, 2016. WHO/HTM/TB/2016.07.

3. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946–1986, with relevant subsequent publications;Fox;Int J Tuberc Lung Dis,1999

4. Caminero JA , Scardigli A , van der Werf TS , et al. Treatment of drug-susceptible and drug-resistant tuberculosis. Eur Respir Monogr 2018: 205–227.

5. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Drug Resistant Tuberculosis With Extensive Bilateral Lung Involvement Can be Cured With Just Three Drugs for 6 Months;Archivos de Bronconeumología;2024-04

2. NEAT1 in inflammatory infectious diseases: An integrated perspective on molecular modulation;Pathology - Research and Practice;2024-02

3. The basis of tuberculosis treatment: fundamental concepts before treating a patient;The Challenge of Tuberculosis in the 21st Century;2023-09-01

4. Prospective Subunit Nanovaccine against Mycobacterium tuberculosis Infection─Cubosome Lipid Nanocarriers of Cord Factor, Trehalose 6,6′ Dimycolate;ACS Applied Materials & Interfaces;2023-06-01

5. Treatment of MDR-TB/HIV/CMV patients under individualized regimes of antimycobacterial therapy;Infusion & Chemotherapy;2022-12-28